SNCA and Parkinson disease: Parkinson’s disease (PD), the most common neurodegenerative disease worldwide, is characterized by a progressive loss of substantia nigra (SN) dopaminergic neurons and accumulation of α-synuclein in the SN (Poewe et al., 2017).